Tuberculosis Research Funding Trends 2005 — 2023
December 13, 2024 – A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023. Significant acceleration of investment — bolstered by broader democratic support from more diversified sources of funding — is necessary to develop and scale up the tools necessary to end TB as a public health crisis by 2030.
Tuberculosis Research Funding Trends 2005—2023, the 19th annual installment of our series assessing the global state of TB R&D, is based on a survey of biomedical research funders conducted by TAG with support from Stop TB Partnership. The report presents new data on funding for TB R&D in 2023, analyzes trends in spending since 2005, and takes a close look at funding for research to develop new TB vaccines.